Evidence for a pathogenic role of extrafollicular, IL-10–producing CCR6+B helper T cells in systemic lupus erythematosus

Significance Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by pathogenic autoantibodies. CD4+T cells are involved, but the identity of the pathogenic B helper T cells is unclear. Notably, the antiinflammatory cytokine interleukin 10 (IL-10) might promote autoantibody production in SLE. Here, we identified a T cell population that expressed CCR6 and promoted antibody production in a partially IL-10–dependent manner. These CCR6+T cells were distinct from previously identified B helper T cells and expanded in mice developing lupus-like disease and in SLE patients, where they spontaneously induced autoantibodies. They were abundant in lymph nodes of SLE patients, but were excluded from B cell follicles. These findings suggest that extrafollicular, IL-10–producing CCR6+T cells play a pathogenic role in SLE. Interleukin 10 (IL-10) is an antiinflammatory cytokine, but also promotes B cell responses and plays a pathogenic role in systemic lupus erythematosus (SLE). CD4+CCR6+IL-7R+T cells from human tonsils produced IL-10 following stimulation by naïve B cells, which promoted B cell immunoglobulin G (IgG) production. These tonsillar CCR6+B helper T cells were phenotypically distinct from follicular helper T (TFH) cells and lacked BCL6 expression. In peripheral blood, a CCR6+T cell population with similar characteristics was identified, which lacked Th17- and TFH-associated gene signatures and differentiation-associated surface markers. CD4+CCR6+T cells expressing IL-10, but not IL-17, were also detectable in the spleens of cytokine reporter mice. They provided help for IgG production in vivo, and expanded systemically in pristane-induced lupus-like disease. In SLE patients, CD4+CCR6+IL-7R+T cells were associated with the presence of pathogenic anti-dsDNA (double-stranded DNA) antibodies, and provided spontaneous help for autoantibody production ex vivo. Strikingly, IL-10–producing CCR6+T cells were highly abundant in lymph nodes of SLE patients, and colocalized with B cells at the margins of follicles. In conclusion, we identified a previously uncharacterized population of extrafollicular B helper T cells, which produced IL-10 and could play a prominent pathogenic role in SLE.

[1]  Systemic Lupus Erythematosus Disease Activity Index , 2020, Definitions.

[2]  R. Flavell,et al.  IL-10 producing regulatory and helper T-cells in systemic lupus erythematosus. , 2019, Seminars in immunology.

[3]  M. Meyer-Hermann,et al.  Regulatory roles of IL-10–producing human follicular T cells , 2019, The Journal of experimental medicine.

[4]  V. Ranzani,et al.  Eomesodermin controls a unique differentiation program in human IL‐10 and IFN‐γ coproducing regulatory T cells , 2018, European journal of immunology.

[5]  R. Flavell,et al.  Intestinal IFN‐&ggr;–producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL‐10 in the inflamed guts of patients with inflammatory bowel disease , 2018, The Journal of allergy and clinical immunology.

[6]  H. Ueno,et al.  A CD4+ T cell population expanded in Lupus blood provides B cell help through IL10 and succinate , 2018, Nature Medicine.

[7]  V. Ranzani,et al.  Repression of miR-31 by BCL6 stabilizes the helper function of human follicular helper T cells , 2017, Proceedings of the National Academy of Sciences.

[8]  D. Galimberti,et al.  Recognition of viral and self‐antigens by TH1 and TH1/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses , 2017, The Journal of allergy and clinical immunology.

[9]  L. Cosmi,et al.  Musculin inhibits human T‐helper 17 cell response to interleukin 2 by controlling STAT5B activity , 2017, European journal of immunology.

[10]  R. Flavell,et al.  The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer. , 2016, Cytokine & growth factor reviews.

[11]  H. Ueno,et al.  T follicular helper (Tfh) cells in lupus: Activation and involvement in SLE pathogenesis , 2016, European journal of immunology.

[12]  D. Pisetsky Anti-DNA antibodies — quintessential biomarkers of SLE , 2016, Nature Reviews Rheumatology.

[13]  A. Annoni,et al.  IL-10-producing forkhead box protein 3-negative regulatory T cells inhibit B-cell responses and are involved in systemic lupus erythematosus. , 2016, The Journal of allergy and clinical immunology.

[14]  E. Bonfá,et al.  Circulating Follicular Helper–Like T Cells in Systemic Lupus Erythematosus: Association With Disease Activity , 2015, Arthritis & rheumatology.

[15]  J. Miyazaki,et al.  TGF-β3-expressing CD4+CD25−LAG3+ regulatory T cells control humoral immune responses , 2015, Nature Communications.

[16]  D. Cavalieri,et al.  IL‐4‐induced gene 1 maintains high Tob1 expression that contributes to TCR unresponsiveness in human T helper 17 cells , 2014, European journal of immunology.

[17]  Alessandro Sette,et al.  Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. , 2013, Immunity.

[18]  A. Korganow,et al.  Circulating TFH Subset Distribution Is Strongly Affected in Lupus Patients with an Active Disease , 2013, PloS one.

[19]  O. Rekvig,et al.  Lupus Nephritis: Enigmas, Conflicting Models and an Emerging Concept , 2013, Molecular Medicine.

[20]  G. Steiner,et al.  Pristane-induced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ and joint inflammation , 2013, Lupus.

[21]  D. Ye,et al.  Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus , 2013, Clinical Rheumatology.

[22]  B. Stockinger,et al.  TH17 cell plasticity in Peyer’s patches is responsible for induction of T cell-dependent IgA responses , 2013, Nature Immunology.

[23]  H. Ueno,et al.  Human tonsil B-cell lymphoma 6 (BCL6)-expressing CD4+ T-cell subset specialized for B-cell help outside germinal centers , 2011, Proceedings of the National Academy of Sciences.

[24]  J. Bluestone,et al.  Control of TH17 cells occurs in the Small Intestine , 2011, Nature.

[25]  A. Cunningham,et al.  B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells , 2011, The Journal of experimental medicine.

[26]  S. Crotty,et al.  Follicular helper CD4 T cells (TFH). , 2011, Annual review of immunology.

[27]  U. Baron,et al.  Epigenetic modification of the human CCR6 gene is associated with stable CCR6 expression in T cells. , 2011, Blood.

[28]  H. Ueno,et al.  Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. , 2011, Immunity.

[29]  P. Meroni,et al.  Updating on the pathogenesis of systemic lupus erythematosus. , 2010, Autoimmunity reviews.

[30]  R. Sabat,et al.  Biology of interleukin-10. , 2010, Cytokine & growth factor reviews.

[31]  Thomas Korn,et al.  Proinflammatory T helper type 17 cells are effective B-cell helpers , 2010, Proceedings of the National Academy of Sciences.

[32]  L. Rönnblom Potential role of IFNα in adult lupus , 2010, Arthritis research & therapy.

[33]  C. Loddenkemper,et al.  CCR6 is expressed on an IL-10–producing, autoreactive memory T cell population with context-dependent regulatory function , 2010, The Journal of experimental medicine.

[34]  D. van Schaardenburg,et al.  Forefoot disease activity in rheumatoid arthritis patients in remission: results of a cohort study , 2010, Arthritis research & therapy.

[35]  S. Tangye,et al.  Early commitment of naïve human CD4+ T cells to the T follicular helper (TFH) cell lineage is induced by IL‐12 , 2009, Immunology and cell biology.

[36]  R. Flavell,et al.  Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation , 2009, Nature Immunology.

[37]  J. Geginat,et al.  Brief Definitive Report Identification and Characterization of Il-10/ifn-–producing Effector-like T Cells with Regulatory Function in Human Blood , 2022 .

[38]  Hai Qi,et al.  SLAM receptors and SAP influence lymphocyte interactions, development and function , 2009, Nature Reviews Immunology.

[39]  R. Flavell,et al.  ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity , 2008, The Journal of experimental medicine.

[40]  J. Berzofsky Faculty Opinions recommendation of TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. , 2007 .

[41]  T. Mcclanahan,et al.  TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell–mediated pathology , 2007, Nature Immunology.

[42]  Chang H. Kim,et al.  Loss of IL-7 Receptor α on CD4+ T Cells Defines Terminally Differentiated B Cell-Helping Effector T Cells in a B Cell-Rich Lymphoid Tissue1 , 2007, The Journal of Immunology.

[43]  L. Cosmi,et al.  Phenotypic and functional features of human Th17 cells , 2007, The Journal of experimental medicine.

[44]  D. Sacks,et al.  CD4+CD25−Foxp3− Th1 cells are the source of IL-10–mediated immune suppression in chronic cutaneous leishmaniasis , 2007, The Journal of experimental medicine.

[45]  Richard A. Flavell,et al.  Conventional T-bet+Foxp3− Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection , 2007, The Journal of experimental medicine.

[46]  F. Sutterwala,et al.  Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. , 2006, Immunity.

[47]  H. Rahn,et al.  Follicular B helper T cell activity is confined to CXCR5hiICOShi CD4 T cells and is independent of CD57 expression , 2006, European journal of immunology.

[48]  Y. Wan,et al.  Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[49]  C. Mackay,et al.  T Follicular Helper Cells Express a Distinctive Transcriptional Profile, Reflecting Their Role as Non-Th1/Th2 Effector Cells That Provide Help for B Cells1 , 2004, The Journal of Immunology.

[50]  D. Gladman,et al.  Systemic lupus erythematosus disease activity index 2000. , 2002, The Journal of rheumatology.

[51]  E. Butcher,et al.  Subspecialization of Cxcr5+ T Cells , 2001, The Journal of experimental medicine.

[52]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[53]  Federica Sallusto,et al.  Follicular B Helper T Cells Express Cxc Chemokine Receptor 5, Localize to B Cell Follicles, and Support Immunoglobulin Production , 2000, The Journal of experimental medicine.

[54]  P. Loetscher,et al.  Cxc Chemokine Receptor 5 Expression Defines Follicular Homing T Cells with B Cell Helper Function , 2000, The Journal of experimental medicine.

[55]  D. Alarcón-Segovia,et al.  Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. , 2000, Arthritis and rheumatism.

[56]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[57]  J. Banchereau,et al.  Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. , 1995, Immunity.

[58]  D. Alarcón-Segovia,et al.  Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus , 1995, The Journal of experimental medicine.

[59]  J. Banchereau,et al.  Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.